Edition:
United Kingdom

Camurus AB (CAMX.ST)

CAMX.ST on Stockholm Stock Exchange

104.60SEK
12:21pm GMT
Change (% chg)

-1.40kr (-1.32%)
Prev Close
106.00kr
Open
106.40kr
Day's High
107.20kr
Day's Low
104.00kr
Volume
8,255
Avg. Vol
49,759
52-wk High
147.80kr
52-wk Low
91.30kr

Chart for

About

Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a... (more)

Overall

Beta: --
Market Cap(Mil.): kr4,585.62
Shares Outstanding(Mil.): 37.28
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Camurus Q4 Operating Loss Widens To SEK ‍66.1​ Million

* Q4 NET SALES SEK ‍5.5​ MILLION VERSUS SEK 37.1 MILLION YEAR AGO

15 Feb 2018

BRIEF-Camurus AB Q4 Net Revenue Sek 5.5 Million Versus Sek 37.1 Million Year Ago

* Q4 NET REVENUE SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO

15 Feb 2018

BRIEF-Camurus Q3 operating loss widens to SEK ‍67.1​ million

* Q3 NET REVENUE SEK ‍12.5​ MILLION VERSUS SEK 30.5 MILLION YEAR AGO

26 Oct 2017

Earnings vs. Estimates